Glenna Mileson - 12 Apr 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role: Chief Financial Officer
Signature: /s/ Glenna Mileson
Issuer symbol: ATHA
Transactions as of: 12 Apr 2022
Net transactions value: +$31,920
Form type: 4
Filing time: 12 Apr 2022, 19:36:51 UTC
Previous filing: 20 Jan 2022
Next filing: 24 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATHA	Common Stock	Options Exercise	$31,920	+3,000	+3.1%	$10.64	100,060	11 Apr 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATHA	Stock Option (right to buy)	Options Exercise	$0	-3,000	-1.8%	$0.000000	167,000	11 Apr 2022	Common Stock	3,000	$10.64	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One forty-eighth (1/48th) of the shares subject to the option will vest on February 18, 2022, and one forty-eighth of the shares subject to the option will vest each month thereafter.